Xconomy’s Digital Events →
Investor sentiment still backing growth for pharma and biotech sectors, but the length and severity of COVID-19’s impact globally has yet to be seen.
Confirmation that the coronavirus has reached pandemic... Read more »
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
What the most successful life sciences fundraising pitch decks all have in common